| Ident. | Authors (with country if any) | Title |
|---|
| 000225 (2021) |
Alexis Lacout [France] ; Pierre Yves Marcy [France] ; Christian Perronne [France] | Re: 'Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients' by Fiolet et al. |
| 000227 (2021) |
Iwein Gyselinck [Belgique] ; Wim Janssens [Belgique] ; Peter Verhamme [Belgique] ; Robin Vos [Belgique] | Rationale for azithromycin in COVID-19: an overview of existing evidence. |
| 000234 (2021) |
Carlos Diaz-Arocutipa [Pérou] ; Ana Bra Ez-Condorena [Pérou] ; Adrian V. Hernandez [Pérou, États-Unis] | QTc prolongation in COVID-19 patients treated with hydroxychloroquine, chloroquine, azithromycin, or lopinavir/ritonavir: A systematic review and meta-analysis. |
| 000242 (2021) |
Basma S. Mansour [Égypte] ; Noha A. Salem [Égypte] ; Ghada Abdel Kader [Égypte] ; Gamal Abdel-Alrahman [Égypte] ; Omayma M. Mahmoud [Égypte] | Protective effect of Rosuvastatin on Azithromycin induced cardiotoxicity in a rat model. |
| 000249 (2021) |
Bianza Moise Bakadia ; Feng He [République populaire de Chine] ; Tiatou Souho [Togo] ; Lallepak Lamboni [Togo] ; Muhammad Wajid Ullah [République populaire de Chine] ; Biaou Ode Boni [République populaire de Chine] ; Abeer Ahmed Qaed Ahmed [République populaire de Chine] ; Biampata Mutu Mukole ; Guang Yang [République populaire de Chine] | Prevention and treatment of COVID-19: Focus on interferons, chloroquine/hydroxychloroquine, azithromycin, and vaccine. |
| 000266 (2021) |
Jean-Michel Scherrmann [France] | Possible Role of ABCB1 in Lysosomal Accumulation of Azithromycin in COVID-19 Therapy. |
| 000295 (2021) |
Zheng Zequn [République populaire de Chine] ; Wu Yujia [République populaire de Chine] ; Qian Dingding [République populaire de Chine] ; Lian Jiangfang [République populaire de Chine] | Off-label use of chloroquine, hydroxychloroquine, azithromycin and lopinavir/ritonavir in COVID-19 risks prolonging the QT interval by targeting the hERG channel. |
| 000334 (2021) |
Jérôme Montnach [France] ; Isabelle Bar [France] ; Flavien Charpentier [France] ; Michel De Waard [France] ; Gildas Loussouarn [France] | Modelling sudden cardiac death risks factors in patients with coronavirus disease of 2019: the hydroxychloroquine and azithromycin case. |
| 000337 (2021) |
Kazimieras Maneikis [Lituanie] ; Ugne Ringeleviciute [Lituanie] ; Justinas Bacevicius [Lituanie] ; Egle Dieninyte-Misiune [Lituanie] ; Emilija Burokaite [Lituanie] ; Gintare Kazbaraite [Lituanie] ; Marta Monika Janusaite [Lituanie] ; Austeja Dapkeviciute [Lituanie] ; Andrius Zucenka [Lituanie] ; Valdas Peceliunas [Lituanie] ; Lina Kryzauskaite [Lituanie] ; Vytautas Kasiulevicius [Lituanie] ; Donata Ringaitiene [Lituanie] ; Birute Zablockiene [Lituanie] ; Tadas Zvirblis [Lituanie] ; Germanas Marinskis [Lituanie] ; Ligita Jancoriene [Lituanie] ; Laimonas Griskevicius [Lituanie] | Mitigating arrhythmia risk in Hydroxychloroquine and Azithromycin treated COVID-19 patients using arrhythmia risk management plan. |
| 000356 (2021) |
Mohamed O. Saad [Qatar] | Letter to the editor about "Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial". |
| 000364 (2021) |
Pravash Budhathoki [Népal] ; Dhan Bahadur Shrestha [Népal] ; Sitaram Khadka [Népal] ; Era Rawal [Népal] | Is Hydroxychloroquine with Azithromycin a Good Combination in COVID-19 Compared to Hydroxychloroquine Alone from Cardiac Perspective? A Systematic Review and Meta-Analysis. |
| 000399 (2021) |
Brahim Halil Özdemir [Turquie] ; Bülent Özlek [Turquie] ; Mehmet Burak Özen [Turquie] ; Ramazan Gündüz [Turquie] ; Nurullah Çetin [Turquie] ; Ali R Za Bilge [Turquie] | Hydroxychloroquine/azithromycin treatment, QT interval and ventricular arrhythmias in hospitalised patients with COVID-19. |
| 000401 (2021) |
Thomas F. O'Connell [États-Unis] ; Christopher J. Bradley [États-Unis] ; Amr E. Abbas [États-Unis] ; Brian D. Williamson [États-Unis] ; Akash Rusia [États-Unis] ; Adam M. Tawney [États-Unis] ; Rick Gaines [États-Unis] ; Jason Schott [États-Unis] ; Alex Dmitrienko [États-Unis] ; David E. Haines [États-Unis] | Hydroxychloroquine/Azithromycin Therapy and QT Prolongation in Hospitalized Patients With COVID-19. |
| 000408 (2021) |
Christine Johnston [États-Unis] ; Elizabeth R. Brown [États-Unis] ; Jenell Stewart [États-Unis] ; Helen C Stankiewicz Karita [États-Unis] ; Patricia J. Kissinger [États-Unis] ; John Dwyer [États-Unis] ; Sybil Hosek [États-Unis] ; Temitope Oyedele [États-Unis] ; Michael K. Paasche-Orlow [États-Unis] ; Kristopher Paolino [États-Unis] ; Kate B. Heller [États-Unis] ; Hannah Leingang [États-Unis] ; Harald S. Haugen [États-Unis] ; Tracy Q. Dong [États-Unis] ; Anna Bershteyn [États-Unis] ; Arun R. Sridhar [États-Unis] ; Jeanne Poole [États-Unis] ; Peter A. Noseworthy [États-Unis] ; Michael J. Ackerman [États-Unis] ; Susan Morrison [États-Unis] ; Alexander L. Greninger [États-Unis] ; Meei-Li Huang [États-Unis] ; Keith R. Jerome [États-Unis] ; Mark H. Wener [États-Unis] ; Anna Wald [États-Unis] ; Joshua T. Schiffer [États-Unis] ; Connie Celum [États-Unis] ; Helen Y. Chu [États-Unis] ; Ruanne V. Barnabas [États-Unis] ; Jared M. Baeten [États-Unis] | Hydroxychloroquine with or without azithromycin for treatment of early SARS-CoV-2 infection among high-risk outpatient adults: A randomized clinical trial. |
| 000409 (2021) |
Michael J. Keane [Australie] | Hydroxychloroquine with or without Azithromycin in Covid-19. |
| 000410 (2021) |
Rahul Choudhary [Oman] ; Gopal K. Bohra [Oman] ; Deepak Kumar [Oman] | Hydroxychloroquine with or without Azithromycin in Covid-19. |
| 000411 (2021) |
Alexandre B. Cavalcanti [Brésil] ; Otávio Berwanger [Brésil] ; Fernando G. Zampieri [Brésil] | Hydroxychloroquine with or without Azithromycin in Covid-19. Reply. |
| 000421 (2021) |
Elif Tanriverd [Turquie] ; Mustafa Çörtük [Turquie] ; Binnaz Zeynep Yildirim [Turquie] ; Efsun Gonca U Ur Chousein [Turquie] ; Demet Turan [Turquie] ; Halit Çinarka [Turquie] ; Mehmet Akif Özgül [Turquie] ; Erdo An Çetinkaya [Turquie] | Hydroxychloroquine plus azithromycin and early hospital admission are beneficial in COVID-19 patients: Turkish experience with real-life data |
| 000448 (2021) |
Philippe Gautret [France] ; Jean-Christophe Lagier [France] ; Stéphane Honoré [France] ; Van Thuan Hoang [Viêt Nam] ; Philippe Colson [France] ; Didier Raoult [France] | Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial revisited. |
| 000479 (2021) |
Carlos Gustavo Wambier [États-Unis] | Focus on clinical outcomes of "Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial". |
| 000527 (2021) |
Luigi Moschini [Italie] ; Marco Loffi [Italie] ; Valentina Regazzoni [Italie] ; Giuseppe Di Tano [Italie] ; Elisa Gherbesi [Italie] ; Gian Battista Danzi [Italie] | Effects on QT interval of hydroxychloroquine associated with ritonavir/darunavir or azithromycin in patients with SARS-CoV-2 infection. |
